Statement Of Comprehensive Income [Abstract]

ABIONYX Pharma - Filing #2816648

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Statement of comprehensive income [abstract]
Profit (loss)
5 822 EUR
5 822 EUR
1 886 EUR
1 886 EUR
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]
Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans
15,000 EUR
15,000 EUR
5,000 EUR
5,000 EUR
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Exchange differences on translation [abstract]
Gains (losses) on exchange differences on translation of foreign operations, net of tax
53,000 EUR
53,000 EUR
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
48,000 EUR
48,000 EUR
0 EUR
Comprehensive income
5 759 EUR
1 891 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.